Trial intelligence / Profile preview

DIDo: Double Icodextrin Dose in Elderly CAPD

NCT01944852Phase 4Completed

Start
Mar 2013
Primary completion
Feb 2020
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

A Phase 4 trial of icodextrin in end stage renal disease (ESRD). Started Mar 2013; status: completed.

02

Drugs

icodextrin
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT01944852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01944852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call